Everything below concerns certificate of analysis. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-11-16. Where a claim depends on a specific study, the study is described rather than over-claimed.
In animal and early human studies, ipamorelin produces pulsatile growth hormone release and a secondary rise in insulin-like growth factor 1. The magnitude and duration of that rise depend on route, sampling schedule, and the baseline endocrine state of the subject. Whether repeated exposure alters the response over time is not firmly settled, since some reports describe stable pulsatility while others note attenuation. Most published data come from small samples, which limits the strength of any general claim about long-term behavior.
Ipamorelin is a synthetic pentapeptide that belongs to the growth hormone secretagogue class of compounds. Its sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2, a structure that differs from natural ghrelin in length and in the presence of non-natural amino acid residues. Early laboratory work described it as a comparatively selective agent that stimulates growth hormone release with limited effect on other pituitary hormones. The compound is supplied as a lyophilized solid for research use and has no identified natural source in the body.
Selectivity is the property most often attached to this peptide. Published animal and early human studies record increases in growth hormone release after administration, with adrenocorticotropic hormone and cortisol responses remaining small by comparison. Effects on appetite-related pathways also appear weaker than those reported for several earlier secretagogues. Reviews that compare members of the growth hormone secretagogue family cite these findings frequently, though the receptor-level explanation for the selectivity continues to be debated rather than settled.
Ipamorelin is a synthetic pentapeptide classified as a growth hormone secretagogue. Its sequence, Aib-His-D-2-Nal-D-Phe-Lys-NH2, combines three non-proteinogenic residues with a C-terminal amide. The N-terminal aminoisobutyric acid unit and the two aromatic D-amino acids distinguish it from peptides assembled only from standard L-amino acids. Its formula is C38H49N9O5, corresponding to an average mass near 711.9 Da. At neutral pH the molecule carries a net positive charge, a property that shapes its behaviour in chromatographic and electrophoretic systems.
The compound was developed at Novo Nordisk during the 1990s as part of a programme seeking secretagogues with improved selectivity. It was described in the peer-reviewed literature in 1998 alongside related pentapeptides from the same series. Investigators advanced it because it raised growth hormone output in animal models while leaving other pituitary hormones comparatively unaffected. The development code NNC 26-0161 appears in earlier reports, and ipamorelin later became the common designation in published work.
| Property | Value | Notes |
|---|---|---|
| Peptide class | Synthetic pentapeptide | GHS-R1a agonist family |
| Receptor target | Ghrelin receptor (GHS-R1a) | G-protein-coupled receptor |
| Sequence length | Five amino acid residues | Includes non-natural residues |
| Primary reported output | Pulsatile growth hormone release | Observed in animal and early human work |
| Molecular formula | C38H49N9O5 | Corresponds to roughly 711.9 g/mol |
Quality claims for research peptides vary widely across suppliers. A certificate of analysis should list purity by chromatography, the mass found by spectrometry, and the analytical conditions used. Independent testing at a third-party laboratory is a common way to check identity and purity, because documents alone cannot confirm what is inside a vial. Purity figures describe the proportion of the target peptide among detected species, and they say nothing about biological activity or sterility.
Lyophilized ipamorelin powder is the form usually supplied for laboratory work. Kept dry, protected from light, and held at minus 20 degrees Celsius or below, it remains stable for extended periods, often measured in years. Once dissolved, the peptide degrades faster through hydrolysis, oxidation, and deamidation, so solutions are typically refrigerated and used within weeks. Repeated freeze-thaw cycles and exposure to alkaline conditions accelerate loss of the parent compound.
Reversed-phase high-performance liquid chromatography is the standard tool for assessing purity. Detection near 214 nanometers captures the peptide backbone, and the resulting chromatogram shows the main peak alongside related impurities. Electrospray ionization mass spectrometry confirms molecular mass and supports sequence verification. Common degradation products include oxidized residues, deamidated forms, and truncated fragments, each appearing as a distinct peak or shoulder in the trace.
The tunable absorption spectrum and high extinction coefficients of quantum dots make them attractive for light harvesting technologies such as photovoltaics. Quantum dots may be able to increase the efficiency and reduce the cost of today's typical silicon photovoltaic cells. According to an experimental report from 2004, quantum dots of lead selenide (PbSe) can produce more than one exciton from one high-energy photon via the process of carrier multiplication or multiple exciton generation (MEG). This compares favorably to today's photovoltaic cells which can only manage one exciton per high-energy photon, with high kinetic energy carriers losing their energy as heat. On the other hand, the quantum-confined ground-states of colloidal quantum dots (such as lead sulfide, PbS) incorporated in wider-bandgap host semiconductors (such as perovskite) can allow the generation of photocurrent from photons with energy below the host bandgap, via a two-photon absorption process, offering another approach (termed intermediate band, IB) to exploit a broader range of the solar spectrum and thereby achieve higher photovoltaic efficiency. Colloidal quantum dot photovoltaics would theoretically be cheaper to manufacture, as they can be made using simple chemical reactions.
On 23 July 1952, a law combined the GDR's municipal districts (Kreise) into 14 regional districts (Bezirke), and subsequently, on 25 July 1952, the state governments transferred their administrative tasks to the new regional districts. With this law, the Länder were in effect dissolved, and the GDR had become a highly centralized state. While they formally remained in existence, they no longer had any political or administrative functions. The Bezirke were drawn without regard to the borders of the Länder and each named after their capitals, from north to south: Rostock, Neubrandenburg, Schwerin, Potsdam, Frankfurt (Oder), Magdeburg, Cottbus, Halle, Leipzig, Erfurt, Dresden, Karl-Marx-Stadt (named Chemnitz until 1953), Gera and Suhl. The Länderkammer also remained in existence and its members were elected in 1954 by combined sessions of the Bezirkstage (district assemblies) in each Land and in 1958 directly by the Bezirkstage. However, on 8 December 1958, the Länderkammer formally dissolved itself with no objections being raised. The Länder continued to exist de jure up until the entry into force of the 1968 Constitution, which formalized their abolition. Due to its special status, East Berlin was originally not counted as a Bezirk. In 1961, after the construction of the Berlin Wall, East Berlin came to be recognised in GDR administration as a 15th district, though it retained a special status until the adoption of the 1968 Constitution formally designated it as Bezirk Berlin.
Cardiovascular diseases, which include diseases of the heart, are the leading cause of death worldwide. The majority of cardiovascular disease is noncommunicable and related to lifestyle and other factors, becoming more prevalent with ageing. An estimated 19.8 million people died of cardiovascular disease in 2022, around 32% of all deaths globally. This rate varies from a lower 28% to a high 40% in high-income countries. Doctors that specialise in the heart are called cardiologists. Many other medical professionals are involved in treating diseases of the heart, including doctors, cardiothoracic surgeons, intensivists, and allied health practitioners including physiotherapists and dieticians.
== External links == Genome-based Peptide Fingerprint Scanning (GFS) Documentation Archived 27 September 2013 at the Wayback Machine Facebook link to "Genome-based Peptide Fingerprint Scanning" Explanation of MS/MS in relation to MASCOT
A 2023 study by Singh et al using higher resolution markers than previous studies found that there was higher gene flow from South India to the Sinhalese than from North India, with the Sinhalese sharing the highest Identity by descent with Tamils, especially the Piramalai Kallars, compared to the other Indian populations studied. The study also found heightened sharing with the Maratha of India, consistent with a West Eurasian contribution .This excess sharing of segments suggests common roots of Sinhala with the Marāṭhā corroborating the linguistic hypothesis of Lazarus Geiger, Ralph Lilley Turner, and George van Driem. The total Sinhalese sample size used was 9 individuals. A 2025 study by Aragon et al again found that the Sinhalese were genetically closer to populations from South India than to populations from North India. The study also failed to find high genetic affinities and allele sharing with North Indian populations. The study collected 35 Sinhalese samples from multiple cities (Galle, Anuradhapura, Kandy, Matale, Ratnapura, Kurunegala, Colombo, Kalutara, and Gampaha) in order to build a more representative picture.
Sources: en.wikipedia.org
=== Parkinson's disease === Mesocarb, has been under development for the treatment of Parkinson's disease since 2016. As of February 2023, it is in phase 1 clinical trials for this indication. However, no recent development has been reported. Mesocarb's active enantiomer armesocarb is also under development.
=== Books === Becker, Katja; Engelen, Eva-Maria; Vec, Miloš (1 January 2003), Ethisierung - Ethikferne: Wie viel Ethik braucht die Wissenschaft? (in German) (1st ed.), Berlin: Walter de Gruyter GmbH & Co.KG, p. 243, ISBN 9783050082219 Becker, Katja; Seltzer, Paul M. (February 2011). Apicomplexan Parasites: Molecular Approaches toward Targeted Drug Development. Drug Discovery in Infectious Diseases. Vol. 2 (1st ed.). Weinheim: Wiley-Blackwell. p. 550. ISBN 978-3-527-32731-7.
Anne Ephrussi (born 15 September 1955 in Paris, France) is a French developmental and molecular biologist. Her research is focused on the study of post-transcriptional regulations such as mRNA localization and translation control in molecular biology as well as the establishment of polarity axes in cell and developmental biology. She is director of the EMBL International Centre for Advanced Training (EICAT) program at the European Molecular Biology Laboratory (EMBL) since 2005 and served as head of the Developmental Biology Unit from 2007 to 2021.
While it is thus possible to use uranium-233 as the fissile material of a nuclear weapon, speculation aside, there is scant publicly available information on this isotope actually having been weaponized:
Metiussl is eventually deleted by Deka Master while Cannon Gladiator is eaten by Gigas, which is subsequently destroyed by Deka Base Robo. Metiussl is voiced by Hisanori Koyatsu (小谷津 央典, Koyatsu Hisanori). Ozchuian Ial (オズチュウ星人イーアル, Ozuchū Seijin Īaru): A kung fu/Drunken Master–themed criminal from Planet Ozchu who is charged with medical violations and homicide, can strengthen himself by drinking alcohol, carries a bottle of Earth sake, and possesses a fighting style tailored to how drunk he is. He poses as a restaurateur named Wang (ワン, Wan) until he is confronted by Umeko, enlarges himself, and is deleted by Dekaranger Robo. Ial is voiced by Dandy Sakano (ダンディ坂野, Dandi Sakano), who also portrays Wang. Woojonian Jinche (ウージョン星人ジンチェ, Wūjon Seijin Jinche): A criminal from Planet Woojon who possesses the ability to swap bodies with another and is wanted on seven planets on burglary and vandalism charges. After being captured by S.P.D. while using a Kaijuki called Shinobi Shadow 2 (シノビシャドー2, Shinobi Shadō Tsū), which was destroyed by Deka Base Robo, he attempts to take over the Deka Base for himself and reveal its secrets to Agent Abrella by switching bodies with Hoji, only to partially succeed in the latter task before he is returned to his original body and deleted by the Dekarangers via the D-Bazooka. Jinche is voiced by Yukitoshi Hori (堀 之紀, Hori Yukitoshi). Guermerlian Byz Goa (ゲルマー星人バイズ・ゴア, Gerumā Seijin Baizu Goa): A tiny planetary bomber and destroyer of worlds, from Planet Geurmerl.
Sources: en.wikipedia.org
It is a synthetic pentapeptide in the growth hormone secretagogue family and acts as an agonist at the ghrelin receptor. It is handled as a laboratory research compound rather than a naturally occurring hormone.
Studies generally report growth hormone as the dominant output, with smaller or absent effects on adrenocorticotropic hormone and prolactin. The size of that separation depends on the assay and the dose examined, so it is best described as relative selectivity.
No natural source has been identified, and the molecule is produced by chemical synthesis. Its non-natural residues distinguish it from endogenous ghrelin even though both engage the same receptor.
It is a synthetic five-amino-acid peptide that acts as a growth hormone secretagogue. Three of its residues are non-standard amino acids, and the chain ends in an amide rather than a free acid. The molecule is small enough that it can be characterised by routine peptide analytical techniques.